FIELD: biotechnology. SUBSTANCE: prepared vaccine against coronaviral enteritis in calves has, wt.-%: suspension of strain Coronavirus bovinus ВГНКИ N8 with biological activity of virus 4.5-6.0 1g ТЦД50/ml 60-70; pepton 6-8; lactose 6-8, and buffer solution (pH 7.2-7.4) - the rest. Preparation is stored in lyophilized dried state. EFFECT: increased immunogenicity of vaccine.
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE AGAINST PLAGUE, ADENOVIRUS INFECTIONS, PARVOVIRUS AND CORONAVIRUS ENTERITIS, LEPTOSPIROSIS AND RABIES OF DOGS | 2013 |
|
RU2546247C2 |
| ASSOCIATED VACCINE AGAINST CANINE DISTEMPER, PARVOVIRUS AND CORONAVIRUS ENTERITIS, ADENOVIRUS INFECTION OF DOGS | 2022 |
|
RU2806164C1 |
| CULTURE VACCINE AGAINST POULTRY POX OUT OF HEN'S VIRUS (OSPOVAC) (VARIANTS) | 2006 |
|
RU2304447C1 |
| POULTRY POX VACCINE PRODUCTION METHOD | 1986 |
|
RU1405148C |
| INACTIVATED COMBINED VACCINE AGAINST CATTLE INFECTIOUS RHINOTRACHEITIS, VIRUS DIARRHOEA, ROTA-, CORONAVIRUS DISEASE AND LEPTOSPIROSIS | 2009 |
|
RU2395299C1 |
| ASSOCIATED VACCINE AGAINST DISTEMPER, PARVOVIRUS AND CORONAVIRUS ENTERITIS, ADENOVIRUS INFECTION AND CANINE RABIES | 2023 |
|
RU2817255C1 |
| RICH STRAIN OF THE CANINE CORONAVIRUS ENTERITIS VIRUS FOR THE MANUFACTURE OF BIOLOGICAL PRODUCTS FOR THE DIAGNOSIS AND SPECIFIC PREVENTION OF CANINE CORONAVIRUS ENTERITIS | 2022 |
|
RU2796988C1 |
| EMULSION INACTIVATED ASSOCIATED VACCINE AGAINST CATTLE PARAGRIPPE-3, REDNOSE AND CORONOVIRAL INFECTION | 2007 |
|
RU2378014C2 |
| EMULSION INACTIVATED ASSOCIATED VACCINE AGAINST CATTLE REDNOSE AND CORONOVIRAL INFECTION | 2007 |
|
RU2378017C2 |
| VACCINE AGAINST CANINE CORONAVIRAL ENTERITIS | 2001 |
|
RU2211705C1 |
